However, according to our knowledge, little is known about diagnostic usefulness of MMP-2 in relation to its tissue inhibitor in the sera of PC patients and in comparison to well-established tumor markers, such as CA 19-9 and CEA. This evidence concerns the gene CEACAM5 and pachyonychia congenita.